The Southeast Asia Health Tech 50 is HolonIQ’s annual list of the most promising startups from across digital health, biotech, medtech and other areas where entrepreneurs are driving healthcare innovation.
Healthcare provision across Southeast Asia is very mixed. Mature healthcare systems in the region offer world-class provision but as a whole, Southeast Asia has lower than average levels of access to care when considered globally. This combination of competence and need has created a vibrant market for health startups with digital players intent on widening access to healthcare in the region gathering momentum. Outside of the urban areas the region’s geography typically makes coverage a challenge logistically, which means connectivity and remote consultations will be increasingly important for healthcare provision across Southeast Asia.
The increasing prevalence of ‘virtual first’ health is clear to see in the 2022 Southeast Asia Health Tech 50.
The 2022 Southeast Asia Health Tech 50 is mapped to the HolonIQ Global Healthcare Landscape, an open-source taxonomy for the future of health and wellness.
By viewing the 2022 cohort against the taxonomy’s clusters it is possible to consider in detail where entrepreneurial activity in the region is being directed. The concentration of startups focused on telehealth and other means of remote consultation reflect the extent to which the pandemic has acted as a catalyst for digital health in the region. Changing attitudes to the role of technology - both within the health profession and among consumers - is leading to rapid adoption of new models of care and digitizing the healthcare system generally. Despite a recent slowdown in the market the past 12 months has seen a range of fast-growth startups raise considerable sums of capital, including: Docquity (peer-to-peer learning platform for health professionals); Homage (home health and care platform); Doctor Anywhere (regional telehealth player); Intellect (modern-day mental healthcare) and Us2.ai (AI platform for imaging analysis)